Filana Therapeutics, Inc. (FLNA) at a glance

Filana Therapeutics, Inc. (FLNA) is a micro-cap Healthcare company. It trades at $1.02, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 53/100 overall. Its strongest dimension is Safety (86/100) and its weakest is Momentum (12/100). It is a relatively defensive holding with below-market volatility.

Price

$1.02

Market cap

$60.4M

P/E ratio

n/a

Dividend yield

None

Beta

-0.78

52-week range

$1.00 to $4.98